ERIC MOFFET: Open Payments
NPI 1609984178 · KINGSPORT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,405 in 168 payments from 15 companies in 2025. Trend: 2023 $3,410 · 2024 $2,839 · 2025 $3,405
Food & beverage: $3,293Education: $111
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 14 | $462 |
| Neurocrine BioSciences, Inc. | 22 | $452 |
| Otsuka America Pharmaceutical, Inc. | 17 | $448 |
| ABBVIE INC. | 35 | $396 |
| Vanda Pharmaceuticals Inc. | 19 | $377 |
| Teva Pharmaceuticals USA, Inc. | 15 | $364 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $278 |
| Lundbeck LLC | 10 | $173 |
| Stryker Corporation | 3 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $124 |
Products named: INGREZZA, VRAYLAR, LYBALVI, ABILIFY MAINTENA, CAPLYTA, HETLIOZ, AUSTEDO XR, REXULTI.
Industry payments across TN — which companies pay providers there.
